Since the establishment of People's Republic of China (PRC), the biological products enterprises affiliated to Zhongsheng Co., Ltd. have been undertaking the production and supply of biological products for preventing, controlling and eliminating infectious diseases in China.
It has strong industrialization ability and production bases in six major cities. Among the 4 1 vaccine varieties that can be produced in China, Zhongsheng Co., Ltd. can produce 35 kinds with an annual output of more than 700 million doses. Zhongsheng Co., Ltd. is also the largest manufacturer of blood products in China. Its products include human albumin, intravenous immunoglobulin, human immunoglobulin and specific immunoglobulin (hepatitis B, tetanus, rabies), which undertakes the task of national central medical reserve.
Beijing Tiantan biological products co., ltd.
The company is one of the research and production bases of biological products and a listed company under the jurisdiction of China Biotechnology Group, a central enterprise. The company is mainly engaged in the research and development, production and sales of biological products such as vaccines, blood preparations and diagnostic supplies.
The leading products include more than 20 varieties such as recombinant yeast hepatitis B vaccine, live rubella vaccine, polio vaccine, inactivated Japanese encephalitis vaccine, combined leprosy vaccine (MR) and various diagnostic reagents. The main products account for more than 50% of the domestic market share. The company workshop has passed SFDA GMP certification. The H 1N 1 influenza vaccine produced by the company has been purchased by the state.
3. Chongqing zhifei Biological Products Co., Ltd.
Chongqing zhifei Biological Products Co., Ltd. is a company mainly engaged in the marketing of biological products. The company distributes A+C meningococcal polysaccharide conjugate vaccine, A+C+Y+W 135 meningococcal polysaccharide vaccine, Haemophilus influenzae type B conjugate vaccine, freeze-dried live attenuated hepatitis A vaccine, micro-card and other products (the above products are exclusively produced and sold in China, and there is no competition of similar products in China), and the marketing network covers 3 1 province/autonomous region/municipality and all parts of the country.
4. Yunnan watson biological Technology Co., Ltd..
Yunnan watson biological Technology Co., Ltd. is a national high-tech enterprise specializing in research and development, production and marketing of vaccine products in biomedical field. The company was established on 200 1 and registered in Kunming, Yunnan.
5. Kexing Holding Biotechnology Co., Ltd..
Beijing Kexing Biological Products Co., Ltd. is a biological high-tech enterprise jointly funded by Kexing Holdings (Hong Kong) Co., Ltd. and Weiming Biomedical Co., Ltd., which was incorporated in Beijing Zhongguancun National Independent Innovation Demonstration Zone on 200 1. At present, Beijing Kexing is listed on the Nasdaq Global Select Market through Kexing Holding Biotechnology Co., Ltd., and it is the only American vaccine enterprise listed in North China.
6. Hualan Bioengineering Co., Ltd..
Hualan Bioengineering Co., Ltd. Hualan Bioengineering Co., Ltd. (formerly known as Hualan Bioengineering Co., Ltd.) was established in 1992. It is a national key high-tech enterprise engaged in the research and development and production of blood products, and passed the GMP certification of blood products industry for the first time in 1998.
7. Liaoning Chengda Biological Co., Ltd..
Liaoning Chengda Biological Co., Ltd. (referred to as "Chengda Biological" for short) was established in Shenyang in June 2002 with the opportunity of introducing the international leading vaccine production technology platform. Adhering to the concept of "facing life, only responsibility" and the core values of "honesty and responsibility", the company is committed to the research, development, production and promotion of "international level and domestic leading" biological products.
Build the company into a respected and influential enterprise in the industry. At present, it has the production capacity of more than 40 million doses of rabies vaccine for human use and 65438+ 1 100 million doses of inactivated Japanese encephalitis vaccine for human use.
8. China Biological Products Co., Ltd
China Biotechnology Group Co., Ltd. was established in 1989 (formerly known as China Biological Products Corporation, renamed in August 2003, hereinafter referred to as Zhongsheng Group), and was originally an important state-owned backbone enterprise managed by the State Council State-owned Assets Supervision and Administration Commission.
In September 2009, with the approval of the State Council, China Pharmaceutical Group Company and China Biotechnology Group Company implemented joint reorganization. At this point, the number of enterprises that SASAC has performed as investors has been adjusted from 136 to 135. China Scientific Equipment Import and Export Corporation and China Medical Equipment Import and Export Corporation, affiliated to Zhongsheng Group, have a wide customer base and mature sales network at home and abroad, and have a long history and high reputation in the fields of science and technology and medical care in China.
9. Shanghai Laishi Blood Products Co., Ltd.
Shanghai Lai Shi Blood Products Co., Ltd. originated from Shanghai Lai Shi Blood Products Co., Ltd., and was established by American Rare Antibody and Antigen Supply Company and Shanghai Blood Center Blood Products Transfusion Equipment Management Company in June 1988. It is the first large-scale blood product manufacturer in China. In March 2007, the company was changed into a joint stock limited company with a registered capital of 654.38+200,000 yuan, of which 50% was contributed by Kerui Tiancheng Investment Holding Co., Ltd. and 50% by Lai Shi China Co., Ltd.
10, Jiangxi Boya Biopharmaceutical Co., Ltd.
Jiangxi Boya Biopharmaceutical Co., Ltd. is located in Fuzhou City, Jiangxi Province, and was established in 1993. It is the only designated production unit of blood products recognized by the state in Jiangxi Province.
China's pursuit of sustainable development has not only created business opportunities for Novozymes, but also influenced multinational enterprises around the world, because the market scale in China is very large, which is a vital driving force for any enterprise. For the rapid rise of a new generation of biopharmaceutical companies, they have shown their talents on the world stage. Analysts believe that now is the best time for small and medium-sized biopharmaceutical companies.
Types of biochemical reagents:
It mainly includes electrophoresis reagent, chromatographic reagent, centrifugal separation reagent, immune reagent, labeling reagent, histochemical reagent, penetrant and carcinogen, insecticide, culture medium, buffer, electron microscope reagent, protein and nucleic acid precipitant, condenser, ultrafiltration membrane, clinical diagnosis reagent, dye, antioxidant, mildew inhibitor, detergent and surfactant, biochemical standard reagent, biochemical quality control reagent, separation material, etc.
Baidu encyclopedia-biochemical reagent